143 related articles for article (PubMed ID: 8625295)
1. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.
Trybus TM; Burgess AC; Wojno KJ; Glover TW; Macoska JA
Cancer Res; 1996 May; 56(10):2263-7. PubMed ID: 8625295
[TBL] [Abstract][Full Text] [Related]
2. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer.
Komiya A; Suzuki H; Ueda T; Yatani R; Emi M; Ito H; Shimazaki J
Genes Chromosomes Cancer; 1996 Dec; 17(4):245-53. PubMed ID: 8946206
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss on chromosome 10 in prostate adenocarcinoma.
Ittmann M
Cancer Res; 1996 May; 56(9):2143-7. PubMed ID: 8616863
[TBL] [Abstract][Full Text] [Related]
4. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
[TBL] [Abstract][Full Text] [Related]
5. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
Ittmann MM
Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
[TBL] [Abstract][Full Text] [Related]
7. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
Vocke CD; Pozzatti RO; Bostwick DG; Florence CD; Jennings SB; Strup SE; Duray PH; Liotta LA; Emmert-Buck MR; Linehan WM
Cancer Res; 1996 May; 56(10):2411-6. PubMed ID: 8625320
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.
Takahashi S; Shan AL; Ritland SR; Delacey KA; Bostwick DG; Lieber MM; Thibodeau SN; Jenkins RB
Cancer Res; 1995 Sep; 55(18):4114-9. PubMed ID: 7664288
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.
Macoska JA; Trybus TM; Sakr WA; Wolf MC; Benson PD; Powell IJ; Pontes JE
Cancer Res; 1994 Jul; 54(14):3824-30. PubMed ID: 8033102
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss in locally metastatic, multisampled prostate cancer.
Sakr WA; Macoska JA; Benson P; Grignon DJ; Wolman SR; Pontes JE; Crissman JD
Cancer Res; 1994 Jun; 54(12):3273-7. PubMed ID: 7515768
[TBL] [Abstract][Full Text] [Related]
11. Loss of the chromosomal region 10q23-25 in prostate cancer.
Gray IC; Phillips SM; Lee SJ; Neoptolemos JP; Weissenbach J; Spurr NK
Cancer Res; 1995 Nov; 55(21):4800-3. PubMed ID: 7585509
[TBL] [Abstract][Full Text] [Related]
12. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site.
Prasad MA; Trybus TM; Wojno KJ; Macoska JA
Genes Chromosomes Cancer; 1998 Nov; 23(3):255-62. PubMed ID: 9790507
[TBL] [Abstract][Full Text] [Related]
13. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D
Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
15. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed BK; McLendon RE; Friedman HS; Friedman AH; Fuchs HE; Bigner DD; Bigner SH
Oncogene; 1995 Jun; 10(11):2243-6. PubMed ID: 7784070
[TBL] [Abstract][Full Text] [Related]
18. A common deletion at chromosomal region 17q21 in sporadic prostate tumors distal to BRCA1.
Dai Q; Deubler DA; Maxwell TM; Zhu XL; Cui J; Rohr LR; Stephenson RA; Brothman AR
Genomics; 2001 Feb; 71(3):324-9. PubMed ID: 11170749
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the malignant phenotype of human prostate cancer cell line PPC-1 by introduction of normal fragments of human chromosome 10.
Murakami YS; Albertsen H; Brothman AR; Leach RJ; White RL
Cancer Res; 1996 May; 56(9):2157-60. PubMed ID: 8616865
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
